SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000920465-20-000045
Filing Date
2020-04-02
Accepted
2020-04-02 18:08:13
Documents
1
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_158586527563021.html 4  
1 FORM 4 wf-form4_158586527563021.xml 4 5647
  Complete submission text file 0000920465-20-000045.txt   6996
Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121
Business Address
Rolke James (Reporting) CIK: 0001693858 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36282 | Film No.: 20770741